Verition Fund Management LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 87 filers reported holding CTI BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2015$40,000
-45.2%
20,608
-20.2%
0.01%
-12.5%
Q2 2014$73,00025,8310.01%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2015
NameSharesValueWeighting ↓
FIRST NEW YORK SECURITIES LLC /NY 191,000$345,710,0000.34%
TFS CAPITAL LLC 1,182,304$2,140,0000.21%
TURNER INVESTMENTS LLC 530,100$959,0000.17%
DRW Securities, LLC 486,953$881,0000.14%
Candriam S.C.A. 1,445,000$2,616,0000.05%
First Heartland Consultants, Inc. 74,624$135,0000.05%
WASHINGTON TRUST Co 410,616$743,0000.05%
EAGLE ASSET MANAGEMENT INC 4,332,630$7,842,0000.04%
JW Asset Management, LLC 52,271$95,0000.04%
OXFORD ASSET MANAGEMENT LLP 702,571$1,272,0000.03%
View complete list of CTI BIOPHARMA CORP shareholders